(object) array( 'id' => '997086', 'url' => 'IT/precaution', 'image' => '', 'title' => 'precauzione', 'tags' => array ( 0 => 'precauzione', 1 => 'Health care', 2 => 'Pharmaceutical', 3 => 'Vaccines', 4 => 'U.S. CDC', 5 => '', ), 'term' => 'precauzione', 'source_id' => 392742, 'type' => 'term', 'namespace' => 1388, 'nstext' => 'IT', 'industry' => array ( 0 => 'Health care', 1 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Vaccines', ), 'company' => array ( 0 => 'U.S. CDC', ), 'lastedit' => '20110408112724', 'part_of_speech' => 'noun', 'creation_user' => 'erotunno', 'special_term' => '', 'definition' => 'Una condizione in un destinatario che può provocare un problema pericoloso se il vaccino è dato, o una condizione che potrebbe compromettere la capacità del vaccino per produrre immunità.', 'usage_comment' => 'MT', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503601808675700736, 'nstext_full' => 'Italian (IT)', 's_attr' => (object) array( 'Term' => 'precaution', 'Definition' => 'A condition in a recipient which may result in a life-threatening problem if the vaccine is given, or a condition which could compromise the ability of the vaccine to produce immunity.', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Industry' => 'Health care; Pharmaceutical', 'Product Category' => 'Vaccines', 'Company' => 'U.S. CDC', 'Creation User' => 'Jacobmc', 'Creation Date' => '2010/10/22', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'precaution', )

(object) array( 'id' => '962582', 'url' => 'IT/the_one_who', 'image' => '', 'title' => 'che/colui che/colei che', 'tags' => array ( 0 => 'che/colui che/colei che', 1 => 'Language', 2 => 'Dictionaries', 3 => 'Tagalog_English_Deutsch_twgid1297315887701002', ), 'term' => 'che/colui che/colei che', 'source_id' => 726372, 'type' => 'term', 'namespace' => 1388, 'nstext' => 'IT', 'industry' => array ( 0 => 'Language', ), 'category' => array ( 0 => 'Dictionaries', ), 'lastedit' => '20110405161401', 'part_of_speech' => 'other', 'creation_user' => 'erotunno', 'special_term' => '', 'definition' => 'funzione Parole; articoli e pronomi; pronome dimostrativo, (deictive determinante)', 'usage_comment' => 'MT', 'glossary' => 'Tagalog_English_Deutsch_twgid1297315887701002', 'width' => 0, 'height' => 0, '_version_' => 1503601655784931329, 'nstext_full' => 'Italian (IT)', 's_attr' => (object) array( 'Term' => 'the one who', 'Definition' => 'function words; articles and pronouns; demonstrative pronoun, (deictive determinative)', 'Part of Speech' => 'other', 'Usage Status' => 'New', 'Industry' => 'Language', 'Product Category' => 'Dictionaries', 'Context' => '* The woman is the one who is sick. * Ang babáe ang maysakít. * Die Frau ist diejenige, die krank ist.', 'Creation User' => 'climatepatrol', 'Creation Date' => '2011/2/11', 'Glossary' => 'Tagalog_English_Deutsch_twgid1297315887701002', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'the_one_who', )

(object) array( 'id' => '963635', 'url' => 'IT/double-blind_study', 'image' => '', 'title' => 'studio a doppio cieco', 'tags' => array ( 0 => 'studio a doppio cieco', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'studio a doppio cieco', 'source_id' => 30890, 'type' => 'term', 'namespace' => 1388, 'nstext' => 'IT', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110405175003', 'part_of_speech' => 'noun', 'creation_user' => 'erotunno', 'special_term' => '', 'definition' => 'Un design di trial clinico in cui né gli individui partecipanti né il personale di studio sa che i partecipanti stanno ricevendo il farmaco sperimentale e che ricevono un placebo (o un\'altra terapia). Prove in doppio-cieco sono pensati per produrre risultati oggettivi, poiché le aspettative del medico e il partecipante circa il farmaco sperimentale non influenzano il risultato; anche chiamato studio in doppio cieco. Vedere cieco studio, studio a singolo-cieco e Placebo.', 'usage_comment' => 'MT', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503601660050538500, 'nstext_full' => 'Italian (IT)', 's_attr' => (object) array( 'Term' => 'double-blind study', 'Definition' => 'A clinical trial design in which neither the participating individuals nor the study staff knows which participants are receiving the experimental drug and which are receiving a placebo (or another therapy). Double-blind trials are thought to produce objective results, since the expectations of the doctor and the participant about the experimental drug do not affect the outcome; also called double-masked study. See Blinded Study, Single-Blind Study, and Placebo.', 'Synonym' => 'double-masked study_₀', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'double-blind_study', )

(object) array( 'id' => '997426', 'url' => 'IT/inactived_vaccine', 'image' => '', 'title' => 'vaccino inattivato', 'tags' => array ( 0 => 'vaccino inattivato', 1 => 'Health care', 2 => 'Pharmaceutical', 3 => 'Vaccines', 4 => 'U.S. CDC', 5 => '', ), 'term' => 'vaccino inattivato', 'source_id' => 392694, 'type' => 'term', 'namespace' => 1388, 'nstext' => 'IT', 'industry' => array ( 0 => 'Health care', 1 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Vaccines', ), 'company' => array ( 0 => 'U.S. CDC', ), 'lastedit' => '20110408114205', 'part_of_speech' => 'noun', 'creation_user' => 'erotunno', 'special_term' => '', 'definition' => 'Un vaccino da virus e batteri che sono stati uccisi attraverso processi fisici o chimici. Questi organismi uccisi non possono causare la malattia.', 'usage_comment' => 'MT', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503601810160484352, 'nstext_full' => 'Italian (IT)', 's_attr' => (object) array( 'Term' => 'inactived vaccine', 'Definition' => 'A vaccine made from viruses and bacteria that have been killed through physical or chemical processes. These killed organisms cannot cause disease.', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Industry' => 'Health care; Pharmaceutical', 'Product Category' => 'Vaccines', 'Company' => 'U.S. CDC', 'Creation User' => 'Jacobmc', 'Creation Date' => '2010/10/22', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'inactived_vaccine', )

(object) array( 'id' => '969843', 'url' => 'IT/Herceptin', 'image' => '', 'title' => 'Herceptin (nome di un farmaco per la cura del cancro al seno)', 'tags' => array ( 0 => 'Herceptin (nome di un farmaco per la cura del cancro al seno)', 1 => 'Pharmaceutical', 2 => '', ), 'term' => 'Herceptin (nome di un farmaco per la cura del cancro al seno)', 'source_id' => 31147, 'type' => 'term', 'namespace' => 1388, 'nstext' => 'IT', 'industry' => array ( 0 => 'Pharmaceutical', ), 'lastedit' => '20110406090141', 'part_of_speech' => 'noun', 'creation_user' => 'erotunno', 'special_term' => '', 'definition' => 'un nome di marchio per Trastuzumab, che è un farmaco per il cancro al seno', 'usage_comment' => 'MT', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503601687079682048, 'nstext_full' => 'Italian (IT)', 's_attr' => (object) array( 'Term' => 'Herceptin', 'Definition' => 'a trademark name for Trastuzumab, which is a breast cancer drug', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Industry' => 'Pharmaceutical', 'Revision User' => 'PetriDish', 'Revision Date' => '2010/05/26', 'Creation User' => 'PetriDish', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'Herceptin', )

(object) array( 'id' => '958803', 'url' => 'IT/bipolar_configuration', 'image' => '', 'title' => 'configurazione bipolare', 'tags' => array ( 0 => 'configurazione bipolare', 1 => 'Medical', 2 => 'Implants and interventional materials', 3 => '', ), 'term' => 'configurazione bipolare', 'source_id' => 45659, 'type' => 'term', 'namespace' => 1388, 'nstext' => 'IT', 'industry' => array ( 0 => 'Medical', ), 'category' => array ( 0 => 'Implants and interventional materials', ), 'lastedit' => '20110405110553', 'part_of_speech' => 'noun', 'creation_user' => 'erotunno', 'special_term' => '', 'definition' => 'avendo due conduttori attivi', 'usage_comment' => 'MT', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503601639487963138, 'nstext_full' => 'Italian (IT)', 's_attr' => (object) array( 'Term' => 'bipolar configuration', 'Definition' => 'having two active leads', 'Domain' => 'Documentation; Marketing; Other', 'Industry' => 'Medical', 'Part of Speech' => 'noun', 'Product Category' => 'Implants and interventional materials', 'Usage Status' => 'New', 'Revision User' => 'Uwe', 'Revision Date' => '2010/6/12', 'Creation User' => 'Uwe', 'Creation Date' => '2010/6/12', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'bipolar_configuration', )

(object) array( 'id' => '997246', 'url' => 'IT/inflammatory_bowel_disease_(IBD)', 'image' => '', 'title' => 'malattia infiammatoria intestinale (IBD: inflammatory bowel disease)', 'tags' => array ( 0 => 'malattia infiammatoria intestinale (IBD: inflammatory bowel disease)', 1 => 'Health care', 2 => 'Pharmaceutical', 3 => 'Vaccines', 4 => 'U.S. CDC', 5 => '', ), 'term' => 'malattia infiammatoria intestinale (IBD: inflammatory bowel disease)', 'source_id' => 392701, 'type' => 'term', 'namespace' => 1388, 'nstext' => 'IT', 'industry' => array ( 0 => 'Health care', 1 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Vaccines', ), 'company' => array ( 0 => 'U.S. CDC', ), 'lastedit' => '20110408113520', 'part_of_speech' => 'noun', 'creation_user' => 'erotunno', 'special_term' => '', 'definition' => 'Un termine generale per qualsiasi malattia caratterizzata da infiammazione dell\'intestino. Gli esempi includono la colite e morbo di Crohn. I sintomi includono dolore addominale, diarrea, febbre, perdita di appetito e perdita di peso.', 'usage_comment' => 'MT', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503601809290166278, 'nstext_full' => 'Italian (IT)', 's_attr' => (object) array( 'Term' => 'inflammatory bowel disease (IBD)', 'Definition' => 'A general term for any disease characterized by inflammation of the bowel. Examples include colitis and Crohn\'s disease. Symptoms include abdominal pain, diarrhea, fever, loss of appetite and weight loss.', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Industry' => 'Health care; Pharmaceutical', 'Product Category' => 'Vaccines', 'Company' => 'U.S. CDC', 'Creation User' => 'Jacobmc', 'Creation Date' => '2010/10/22', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'inflammatory_bowel_disease_(IBD)', )

(object) array( 'id' => '997429', 'url' => 'IT/inapparent_infection', 'image' => '', 'title' => 'infezione latente', 'tags' => array ( 0 => 'infezione latente', 1 => 'Health care', 2 => 'Pharmaceutical', 3 => 'Vaccines', 4 => 'U.S. CDC', 5 => '', ), 'term' => 'infezione latente', 'source_id' => 392695, 'type' => 'term', 'namespace' => 1388, 'nstext' => 'IT', 'industry' => array ( 0 => 'Health care', 1 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Vaccines', ), 'company' => array ( 0 => 'U.S. CDC', ), 'lastedit' => '20110408114211', 'part_of_speech' => 'noun', 'creation_user' => 'erotunno', 'special_term' => '', 'definition' => 'La presenza di infezione senza sintomi. Noto anche come infezione subclinica o asintomatica.', 'usage_comment' => 'MT', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503601810163630080, 'nstext_full' => 'Italian (IT)', 's_attr' => (object) array( 'Term' => 'inapparent infection', 'Definition' => 'The presence of infection without symptoms. Also known as subclinical or asymptomatic infection.', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Industry' => 'Health care; Pharmaceutical', 'Product Category' => 'Vaccines', 'Company' => 'U.S. CDC', 'Creation User' => 'Jacobmc', 'Creation Date' => '2010/10/22', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'inapparent_infection', )

(object) array( 'id' => '962394', 'url' => 'IT/intension_₁', 'image' => '', 'title' => 'intensione', 'tags' => array ( 0 => 'intensione', 1 => 'Language', 2 => 'Grammar', 3 => '', ), 'term' => 'intensione', 'source_id' => 506807, 'type' => 'term', 'namespace' => 1388, 'nstext' => 'IT', 'industry' => array ( 0 => 'Language', ), 'category' => array ( 0 => 'Grammar', ), 'lastedit' => '20110405160055', 'part_of_speech' => 'noun', 'creation_user' => 'erotunno', 'special_term' => '', 'definition' => 'insieme intensione (antonimo: estensione) delle caratteristiche che identificano il concetto e differenziarlo da altri concetti (ISO 704:2000 (E): terminologia lavoro: principi e metodo).', 'usage_comment' => 'MT', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503601655058268162, 'nstext_full' => 'Italian (IT)', 's_attr' => (object) array( 'Term' => 'intension', 'Definition' => 'intension (antonym:extension) set of characteristics which identify the concept and differentiate it from other concepts (ISO 704:2000(E):Terminology Work:Principles and Method).', 'Part of Speech' => 'noun', 'Usage Status' => 'New', 'Industry' => 'Language', 'Product Category' => 'Grammar', 'Domain' => 'Documentation', 'Creation User' => 'gwenparapluie', 'Creation Date' => '2010/12/13', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'intension_₁', )

(object) array( 'id' => '997423', 'url' => 'IT/psychotropic_₁', 'image' => '', 'title' => 'sostanza psicotropa', 'tags' => array ( 0 => 'sostanza psicotropa', 1 => 'Pharmaceutical', 2 => 'Drugs', 3 => '', ), 'term' => 'sostanza psicotropa', 'source_id' => 496647, 'type' => 'term', 'namespace' => 1388, 'nstext' => 'IT', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Drugs', ), 'lastedit' => '20110408114158', 'part_of_speech' => 'noun', 'creation_user' => 'erotunno', 'special_term' => '', 'definition' => 'Una droga, pianta, ecc.: che colpiscono la mente; psicoattive', 'usage_comment' => 'MT', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503601810159435778, 'nstext_full' => 'Italian (IT)', 's_attr' => (object) array( 'Term' => 'psychotropic', 'Definition' => 'A drug, plant, etc.: affecting the mind; psychoactive', 'Part of Speech' => 'noun', 'Usage Status' => 'New', 'Synonym' => 'psychotomimetic_₀', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Drugs', 'Domain' => 'Documentation', 'Creation User' => 'emmafrye', 'Creation Date' => '2010/12/2', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'psychotropic_₁', )